Natasha Marrus is a board-certified child and adolescent psychiatrist and associate professor of psychiatry at Washington University School of Medicine in St. Louis. She has more than 10 years of experience in developmental neuroimaging and applying novel phenotyping of autism-relevant behaviors in infancy to quantify their relationship to later autism outcomes.
Natasha Marrus
Associate professor of psychiatry
Washington University School of Medicine in St. Louis
From this contributor
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024
6 min read
Autism is more heritable in boys than in girls
If boys have greater inherited liability for autism, the female protective effect may not fully explain the sex difference in prevalence.
Autism is more heritable in boys than in girls
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024 | 6 min read
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read